Edwards Lifesciences EW Ratios & Valuation
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| Profitability | ||||||
| Gross margin | 77.9%-0.1pp | 78%-0.2pp | 78.2%-0.7pp | 78.9%-0.6pp | 79.5%0.0pp | |
| Operating margin | 21.4%+0.5pp | 20.8%-3.4pp | 24.2%-1.6pp | 25.8%0.0pp | 25.8%+0.4pp | |
| Net margin | 17.4%-0.3pp | 17.7%-5.6pp | 23.2%-49.7pp | 73%-2.8pp | 75.7%-1.0pp | |
| Returns | ||||||
| Return on equity | 10.7%+0.2pp | 10.6%-3.3pp | 13.9%-32.3pp | 46.1%-2.4pp | 48.5%-1.7pp | |
| Return on invested capital | 13.7%+0.4pp | 13.3%-3.1pp | 16.4%-1.2pp | 17.6%-0.2pp | 17.8%-0.2pp | |
| Efficiency | ||||||
| Asset turnover | 0.5×0.0× | 0.5×0.0× | 0.4×0.0× | 0.5×0.0× | 0.5×0.0× | |
| Liquidity | ||||||
| Current ratio | 4.4×+0.7× | 3.7×-0.3× | 4×-0.7× | 4.7×+0.2× | 4.5×+0.3× | |
| Leverage | ||||||
| Debt-to-equity | 0.1×0.0× | 0.1×0.0× | 0.1×0.0× | 0.1×0.0× | 0.1×0.0× | |
| Net debt / EBITDA | -1.2×+0.4× | -1.6×-0.3× | -1.3×+0.3× | -1.6×0.0× | -1.6×0.0× | |
| Per Share | ||||||
| Book value per share | $17.78+0.8% | $17.65+1.3% | $17.42-2.9% | $17.94+4.1% | $17.23+3.3% | |
| Valuation | ||||||
| Market capitalization | $46.17B-6.7% | $49.47B+8.3% | $45.66B+2.6% | $44.49B+4.8% | $42.46B-2.8% | |
| Price / earnings | 42.1×-4.0× | 46.1×+12.7× | 33.4×+22.7× | 10.7×+0.6× | 10.2×-0.3× | |
| Price / sales | 7.3×-0.8× | 8.2×+0.4× | 7.8×-0.1× | 7.8×+0.1× | 7.7×-0.3× | |
| Price / book | 4.5×-0.3× | 4.8×+0.3× | 4.5×+0.3× | 4.2×0.0× | 4.2×-0.2× | |
| EV / EBITDA | 29.5×-3.8× | 33.2×+5.6× | 27.6×+1.7× | 25.9×+0.5× | 25.4×-1.6× |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Edwards Lifesciences's profit margins?
- Edwards Lifesciences (EW) runs a 77.9% gross margin and a 21.4% operating margin, with a 17.4% net margin.
- Where do Edwards Lifesciences's ratios come from?
- Every ratio is computed from Edwards Lifesciences's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
